For example, the expression of TLR2, TLR4, and TLR9 on CD4+ and CD8+ T cells was significantly higher in patients with relapsing remitting MS (RRMS) than healthy individuals (44). This evidence concerns the gene CD8A and relapsing-remitting multiple sclerosis.